Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

Completed

Phase 3 Results

Summary of Purpose

RATIONALE: - Atherothrombosis is a progressive and generalized vascular disease resulting in events leading to myocardial infarction (heart attack), stroke, and vascular death. - In patients at risk for this disease, it is characterized by an unpredictable, sudden disruption of atherosclerotic plaques, which may lead to total occlusion of artery due to formation of a clot. The use of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 April 2012.

1 Oct 2002 20 Dec 2002 Unavailable 1 Aug 2005 1 Apr 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Liz Fabry-Ribaudo RN, MSN Project Manager Cleveland Clinic Cardiovascular Coordinating Center JJ50 9500 Euclid Ave., Cleveland, Ohio 44195 Office: 216-445-4354

    fabryl@ccf.org